background
infecti
diarrhea
common
problem
develop
world
especi
among
peopl
live
hivaid
tradit
diagnost
method
stool
cultur
microscop
examin
limit
resourc
poor
sensit
use
molecular
diagnost
enteropathogen
detect
region
subsaharan
africa
fulli
explor
sought
identifi
risk
factor
character
enteropathogen
diarrheic
stool
hivposit
patient
gondar
ethiopia
use
multiplex
molecular
panel
target
key
infecti
agent
method
crosssect
studi
stool
sampl
perform
sampl
collect
consecut
hivposit
patient
present
diarrhea
univers
gondar
hospit
clinic
major
center
nw
ethiopia
genom
dna
extract
stool
process
use
multiplex
molecular
panel
seegen
canada
correl
patient
characterist
symptom
public
health
risk
factor
enteropathogen
type
studi
eightysix
sampl
success
analyz
molecular
method
result
mean
age
male
eighti
percent
live
urban
area
access
well
water
practic
proper
hand
hygien
major
patient
receiv
haart
median
cell
count
multipl
pathogen
detect
specimen
averag
enteropathogen
per
sampl
common
bacteria
virus
parasit
detect
shigella
sppenteroinvas
e
coli
enterotoxigen
e
coli
noroviru
b
homini
cell
count
associ
presenc
virus
p
absenc
stec
p
use
haart
level
associ
number
enteropathogen
detect
conclus
diarrheic
stool
hivposit
outpati
gondar
ethiopia
averag
enteropathogen
present
stool
shigellasppenteroinvas
e
coli
enterotoxigen
e
coli
major
pathogen
dissimilar
immunocompet
individu
low
incom
countri
diarrheal
ill
contribut
signific
mortal
morbid
within
hivposit
popul
account
death
children
worldwid
death
rate
increas
fold
children
hiv
furthermor
diarrhea
associ
reduc
qualiti
life
caus
psycholog
social
burden
afflict
patient
notabl
lowresourc
set
ethiopia
hivaid
occur
adult
varieti
organ
known
caus
diarrhea
present
inher
challeng
treatment
clinician
diagnosi
laboratori
due
shortag
reagent
laboratori
set
skill
manpow
develop
countri
clinic
laboratori
current
util
array
differ
methodolog
test
bacteri
parasit
viral
caus
diarrhea
among
hivaid
patient
strategi
suffer
poor
sensit
potenti
long
turnaround
time
complic
order
practic
workflow
addit
limit
test
method
routin
avail
diarrheagen
escherichia
coli
strain
certain
enter
virus
molecular
techniqu
enteropathogen
detect
provid
comprehens
rapid
streamlin
altern
convent
method
microbiolog
diagnosi
diarrhea
laboratori
set
potenti
advantag
includ
improv
perform
paramet
extens
menu
pathogen
turnaround
time
short
h
diagnost
yield
term
pathogen
detect
also
approxim
higher
multipl
enteropathogen
commonli
detect
per
sampl
occur
posit
sampl
preval
enteropathogen
region
depend
stark
differ
develop
develop
countri
studi
conduct
unit
state
diarrheal
stool
use
biofir
platform
detect
wide
varieti
enteropathogen
approxim
half
stool
sampl
collect
studi
epec
c
difficil
eaec
noroviru
gigii
preval
organ
detect
posit
sampl
multipl
enteropathogen
contrast
studi
diarrheal
stool
symptomat
peruvian
demonstr
higher
preval
diarrheagen
e
coli
strain
mix
enteropathogen
common
organ
detect
studi
shigella
spp
enteroinvas
e
coli
eiec
g
lamblia
enteroaggreg
e
coli
eaec
enterotoxigen
e
coli
etec
addit
sampl
contain
mix
enteropathogen
studi
aim
identifi
epidemiolog
risk
factor
character
enteropathogen
diarrheic
stool
hivposit
patient
gondar
ethiopia
use
multiplex
molecular
panel
target
key
infecti
agent
diarrheic
stool
collect
consecut
pediatr
adult
patient
hiv
attend
antiretrovir
therapi
art
clinic
univers
gondar
hospit
ethiopia
januari
may
patient
diarrhea
defin
loos
wateri
stool
period
includ
studi
acut
chronic
diarrhea
defin
diarrhea
last
less
week
greater
week
respect
patient
antibiot
antiparasit
agent
exclud
sociodemograph
data
collect
via
patient
questionnair
creat
amhar
facetofac
patient
interview
studi
protocol
review
approv
research
ethic
committe
school
biomed
laboratori
scienc
colleg
medicin
health
scienc
univers
gondar
permiss
letter
obtain
art
clinic
univers
gondar
hospit
inform
assent
written
consent
obtain
studi
particip
explain
object
benefit
risk
studi
vernacular
languag
studi
particip
could
understand
diarrheic
stool
collect
site
use
steril
contain
wet
mount
microscopi
use
direct
salin
iodin
smear
modifi
acidfast
stain
perform
detect
cryptosporidium
isospora
cyclospora
speci
stool
microscopi
perform
two
experienc
laboratori
technologist
discord
result
resolv
local
microbiolog
expert
microscopi
perform
specimen
store
month
molecular
test
perform
total
nucleic
acid
extract
stool
specimen
use
qiaamp
dna
stool
mini
kit
qiagen
germani
accord
manufactur
instruct
subsequ
store
extract
stool
dna
ship
univers
calgari
calgari
alberta
molecular
analysi
use
correl
patient
characterist
symptom
epidemiolog
risk
factor
enteropathogen
explor
use
stata
version
categor
variabl
analyz
use
pearson
chisquar
fisher
exact
test
continu
variabl
analyz
use
two
pair
ttest
normal
distribut
variabl
twosampl
wilcoxon
ranksum
test
nonnorm
distribut
variabl
linear
regress
spearman
rank
test
two
continu
variabl
diarrheic
stool
patient
collect
fourteen
sampl
exclud
molecular
test
arm
due
insuffici
sampl
volum
sampl
process
defici
patient
demograph
outlin
tabl
mean
age
patient
age
patient
male
live
urban
area
access
well
water
access
proper
latrin
practic
proper
hand
hygien
patient
median
durat
diarrhea
day
acut
diarrhea
chronic
diarrhea
median
bowel
movement
frequenc
per
day
median
cell
count
cell
count
major
patient
receiv
highli
activ
antiretrovir
therapi
haart
time
collect
specimen
posit
intestin
parasit
use
wet
mount
modifi
acid
fast
stain
c
parvum
common
parasit
follow
e
histolytica
g
lamblia
c
cayetanensi
stercorali
hookworm
enteropathogen
detect
panel
outlin
fig
older
age
associ
campylobact
spp
occur
patient
age
p
fragili
associ
increas
frequenc
diarrhea
median
movement
fragili
present
compar
median
p
use
well
water
associ
cryptosporidium
well
water
vs
p
box
plot
describ
enteropathogen
frequenc
cell
count
outlin
fig
viral
enteropathogen
stec
associ
cell
count
cell
count
associ
presenc
viral
enteropathogen
p
absenc
stec
p
tabl
lower
cell
count
also
associ
longer
durat
diarrhea
p
older
age
p
associ
organ
count
analyz
none
found
statist
signific
number
organ
detect
one
sampl
associ
specif
demograph
includ
cell
count
administr
haart
age
durat
diarrhea
frequenc
diarrhea
also
case
exclud
b
homini
fragili
aeromona
spp
detect
intestin
parasit
overal
higher
use
multiplex
pcr
compar
microscopi
studi
cryptosporidium
spp
detect
similar
multiplex
pcr
yield
g
lamblia
b
homini
fragili
less
e
histolytica
c
cayetanensi
notabl
microscopi
unabl
distinguish
e
histolytica
pathogen
e
dispar
nonpathogen
wherea
molecular
detect
specif
e
histolytica
multiplex
pcr
known
sensit
convent
techniqu
parasit
detect
therefor
clear
c
cayetanensi
detect
use
multiplex
pcr
studi
shigella
spp
enteroinvas
enteroinvas
e
coli
commonli
detect
organ
studi
follow
epec
similar
studi
among
symptomat
peruvian
shigella
sppenteroinvas
e
coli
commonli
detect
organ
follow
g
lamblia
eaec
etec
epec
glamblia
lower
preval
studi
contrast
detect
diarrheagen
e
coli
strain
much
lower
examin
stool
patient
develop
countri
highlight
common
frequenc
sanit
poor
set
even
asymptomat
individu
preval
diarrheagen
strain
e
coli
high
develop
countri
instanc
one
studi
detect
enteropathogen
asymptomat
travel
epec
eaec
etec
commonli
detect
respect
studi
report
preval
enter
virus
common
noroviru
gigii
find
higher
report
studi
examin
diarrheal
stool
adult
hivaid
show
enter
viru
preval
howev
studi
done
use
less
sensit
convent
techniqu
studi
examin
microbiolog
etiolog
diarrhea
adult
peruvian
detect
enter
virus
multiplex
pcr
sampl
major
noroviru
gigii
knowledg
studi
yet
examin
diarrheic
stool
hiv
aid
patient
use
multiplex
pcr
comparison
debat
exist
literatur
whether
b
homini
fragili
aeromona
spp
true
enteropathogen
virul
potenti
among
sever
studi
examin
hiv
popul
statist
signific
differ
b
homini
found
hiv
patient
without
diarrhea
fragili
found
hivneg
hivposit
individu
sever
studi
hivposit
patient
report
higher
detect
aeromona
spp
diarrhea
compar
without
lack
control
group
unfortun
make
studi
unabl
draw
conclus
respect
aforement
organ
intrins
virul
correspond
known
literatur
lower
cell
count
studi
associ
longer
durat
diarrhea
lower
cell
count
associ
known
opportunist
enteropathogen
cryptosporidium
isospora
sampl
size
small
n
detect
associ
lower
cell
count
presenc
enter
virus
noroviru
giii
rotaviru
adenoviru
studi
one
viru
detect
cell
count
sever
studi
associ
enter
virus
advanc
hiv
infect
suggest
defici
help
mediat
enter
viral
replic
infect
astroviru
implic
potenti
opportunist
pathogen
none
detect
studi
studi
examin
stool
symptomat
hiv
patient
diarrhea
london
uk
found
adenoviru
rotaviru
associ
significantli
lower
cell
count
compar
coronaviru
noroviru
studi
found
rotaviru
noroviru
independ
associ
lower
cell
count
adenoviru
occur
frequent
lower
cell
count
statist
signific
like
due
small
sampl
size
studi
n
ninetyfour
percent
specimen
studi
contain
mixtur
enteropathogen
averag
organ
per
sampl
exclud
b
homini
fragili
aeromona
spp
preval
mix
infect
still
high
mean
organ
per
sampl
high
preval
mix
enteropathogen
demonstr
stool
resid
travel
develop
countri
instanc
stool
specimen
asymptomat
travel
travel
diarrhea
respect
two
bacteri
pathogen
present
use
molecular
techniqu
stool
sampl
symptomat
peruvian
mix
enteropathogen
present
mean
pathogen
per
specimen
test
use
panel
longitudin
cohort
studi
infant
dhaka
bangladesh
multipl
enteropathogen
also
observ
asymptomat
surveil
diarrheal
stool
averag
number
organ
respect
contrast
enteropathogen
detect
nondiarrh
stool
sampl
taken
infant
within
first
year
life
virginia
us
studi
sever
limit
notabl
control
group
comparison
overal
sampl
size
larg
enough
provid
reliabl
conclus
less
commonli
detect
enteropathogen
eg
cryptosporidium
spp
campylobact
spp
convent
approach
includ
cultur
microscopi
antigenbas
test
signific
limit
limit
detect
need
labourintens
procedur
molecular
diagnost
especi
pcr
base
test
rapidli
chang
research
practic
infecti
diseas
syndrom
approach
diagnosi
diarrheal
diseas
broad
rang
potenti
infecti
etiolog
may
benefit
use
multiplex
molecular
format
howev
applic
due
cost
capit
equip
requir
develop
countri
unclear
studi
found
high
number
mix
enteropathogen
diarrheal
stool
taken
symptomat
hiv
patient
ethiopia
use
multiplex
pcr
knowledg
first
studi
demonstr
find
peopl
live
hivaid
develop
set
use
multiplex
molecular
method
specimen
mix
diarrheagen
e
coli
strain
similar
preval
seen
among
diarrheal
stool
symptomat
peruvian
find
highlight
difficulti
determin
colon
versu
infect
use
extrem
sensit
diagnost
method
multiplex
pcr
specif
etiolog
role
organ
individu
patient
use
quantit
cutoff
enteropathogen
detect
use
multiplex
pcr
explor
clinic
studi
need
especi
develop
countri
high
rate
colon
diarrheagen
strain
e
coli
exist
one
concern
inappropri
antimicrobi
use
may
escal
technolog
without
fuller
understand
infect
versu
colon
nevertheless
simplif
technolog
reduct
cost
better
clinic
understand
undoubtedli
enhanc
patient
manag
conclus
multiplex
pcr
panel
elabor
far
greater
complex
infect
hiv
patient
tradit
method
resourcelimit
set
establish
true
etiolog
diarrhea
treatment
approach
remain
challeng
cell
count
associ
increas
detect
gastrointestin
virus
interest
find
requir
investig
